TY - JOUR
T1 - Efficiency of pretreatment risk stratification systems for prostate cancer in a japanese population treated with radical prostatectomy
AU - Koie, Takuya
AU - Mitsuzuka, Koji
AU - Narita, Shintaro
AU - Yoneyama, Takahiro
AU - Kawamura, Sadafumi
AU - Tsuchiya, Norihiko
AU - Tochigi, Tatsuo
AU - Habuchi, Tomonori
AU - Arai, Yoichi
AU - Ohyama, Chikara
N1 - Publisher Copyright:
© 2014 The Japanese Urological Association.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Objective: To determine whether the currently available pretreatment risk classification systems are applicable in Japanese prostate cancer patients. Methods: Using data obtained from 1264 consecutive patients with prostate cancer treated with radical prostatectomy at four hospitals in Japan, biochemical recurrence-free survival rates were estimated and compared between the D'Amico, the National Institute for Health and Clinical Excellence, the Cancer of the Prostate Strategic Urological Research Endeavor, the National Comprehensive Cancer Network, and the European Society of Medical Oncology risk groups by using the Kaplan-Meier method and log-rank test. Results: The 5-year biochemical recurrence-free survival rates in the D'Amico low-, intermediate-, and high-risk groups were 88.3%, 84.7% and 66.9%, respectively (low and intermediate risk vs high risk, P<0.001). The 5-year biochemical recurrence-free survival rates in the National Institute for Health and Clinical Excellence, National Comprehensive Cancer Network, and European Society of Medical Oncology low-, intermediate- and high-risk groups were 88.3%, 84.3%, and 60.3%, respectively (low and intermediate risk vs high risk, P<0.001). The 5-year biochemical recurrence-free survival rates in the Cancer of the Prostate Strategic Urological Research Endeavor low-, intermediate-, and high-risk groups were 90%, 83.5% and 60.3%, respectively (low and intermediate risk vs high risk, P<0.001). Low- and intermediate-risk groups according to any of the risk stratification systems did not show significant differences in biochemical recurrence-free survival. Conclusion: Current risk stratification systems do not discriminate between low- and intermediate-risk groups in the Japanese population. A novel, pretreatment risk stratification system including other prognostic factors is necessary for an adequate prostate cancer risk assessment in the Japanese population.
AB - Objective: To determine whether the currently available pretreatment risk classification systems are applicable in Japanese prostate cancer patients. Methods: Using data obtained from 1264 consecutive patients with prostate cancer treated with radical prostatectomy at four hospitals in Japan, biochemical recurrence-free survival rates were estimated and compared between the D'Amico, the National Institute for Health and Clinical Excellence, the Cancer of the Prostate Strategic Urological Research Endeavor, the National Comprehensive Cancer Network, and the European Society of Medical Oncology risk groups by using the Kaplan-Meier method and log-rank test. Results: The 5-year biochemical recurrence-free survival rates in the D'Amico low-, intermediate-, and high-risk groups were 88.3%, 84.7% and 66.9%, respectively (low and intermediate risk vs high risk, P<0.001). The 5-year biochemical recurrence-free survival rates in the National Institute for Health and Clinical Excellence, National Comprehensive Cancer Network, and European Society of Medical Oncology low-, intermediate- and high-risk groups were 88.3%, 84.3%, and 60.3%, respectively (low and intermediate risk vs high risk, P<0.001). The 5-year biochemical recurrence-free survival rates in the Cancer of the Prostate Strategic Urological Research Endeavor low-, intermediate-, and high-risk groups were 90%, 83.5% and 60.3%, respectively (low and intermediate risk vs high risk, P<0.001). Low- and intermediate-risk groups according to any of the risk stratification systems did not show significant differences in biochemical recurrence-free survival. Conclusion: Current risk stratification systems do not discriminate between low- and intermediate-risk groups in the Japanese population. A novel, pretreatment risk stratification system including other prognostic factors is necessary for an adequate prostate cancer risk assessment in the Japanese population.
KW - Japanese population
KW - Low- and intermediate risk
KW - Prostate cancer
KW - Prostatectomy
KW - Risk stratification
UR - http://www.scopus.com/inward/record.url?scp=84920987479&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84920987479&partnerID=8YFLogxK
U2 - 10.1111/iju.12597
DO - 10.1111/iju.12597
M3 - Article
C2 - 25115632
AN - SCOPUS:84920987479
VL - 22
SP - 70
EP - 73
JO - International Journal of Urology
JF - International Journal of Urology
SN - 0919-8172
IS - 1
ER -